Corticosterone inhibits the lipid-mobilizing effects of oleoyl-estrone in adrenalectomized rats. 2007

Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
Department of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain.

Oleoyl-estrone (OE) is an adipose-derived signal that decreases energy intake and body lipid, maintaining energy expenditure and glycemic homeostasis. Glucocorticoids protect body lipid and the metabolic status quo. We studied the combined effects of OE and corticosterone in adrenalectomized female rats: daily OE gavages (0 or 10 nmol/g) and slow-release corticosterone pellets at four doses (0, 0.5, 1.7, and 4.8 mg/d). Intact and sham-operated controls were also included. After 8 d, body composition and plasma metabolites and hormones were measured. OE induced a massive lipid mobilization (in parallel with decreased food intake and maintained energy expenditure). Corticosterone increased fat deposition and inhibited the OE-elicited mobilization of body energy, even at the lowest dose. OE enhanced the corticosterone-induced rise in plasma triacylglycerols, and corticosterone blocked the OE-induced decrease in leptin. High corticosterone and OE increased insulin resistance beyond the effects of corticosterone alone. The presence of corticosterone dramatically affected OE effects, reversing its decrease of body energy (lipid) content, with little or no change on food intake or energy expenditure. The maintenance of glycemia and increasing insulin in parallel to the dose of corticosterone indicate a decrease in insulin sensitivity, which is enhanced by OE. The reversal of OE effects on lipid handling, insulin resistance, can be the consequence of a corticosterone-induced OE resistance. Nevertheless, OE effects on cholesterol were largely unaffected. In conclusion, corticosterone administration effectively blocked OE effects on body lipid and energy balance as well as insulin sensitivity and glycemia.

UI MeSH Term Description Entries
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D004970 Estrone An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women. Folliculin (Hormone),Estrone, (+-)-Isomer,Estrone, (8 alpha)-Isomer,Estrone, (9 beta)-Isomer,Estrovarin,Kestrone,Unigen,Wehgen
D005260 Female Females
D000315 Adrenalectomy Excision of one or both adrenal glands. (From Dorland, 28th ed) Adrenalectomies
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
June 2007, Journal of pharmacological sciences,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
July 2001, Life sciences,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
August 1998, The Journal of steroid biochemistry and molecular biology,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
January 1998, Life sciences,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
June 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
April 2005, European journal of pharmacology,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
February 2001, European journal of nutrition,
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
December 2010, Obesity (Silver Spring, Md.),
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
January 2011, Nutrition (Burbank, Los Angeles County, Calif.),
Maria del Mar Grasa, and Marta Serrano, and José Antonio Fernández-López, and Marià Alemany
September 1976, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
Copied contents to your clipboard!